Pacific Stock Based Compensation vs Capital Expenditures Analysis

PACB Stock

USD 1.99 0.19 10.56%

Pacific Biosciences financial indicator trend analysis is much more than just breaking down Pacific Biosciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Pacific Biosciences is a good investment. Please check the relationship between Pacific Biosciences Stock Based Compensation and its Capital Expenditures accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Stock Based Compensation vs Capital Expenditures

Stock Based Compensation vs Capital Expenditures Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Pacific Biosciences Stock Based Compensation account and Capital Expenditures. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between Pacific Biosciences' Stock Based Compensation and Capital Expenditures is 0.59. Overlapping area represents the amount of variation of Stock Based Compensation that can explain the historical movement of Capital Expenditures in the same time period over historical financial statements of Pacific Biosciences of, assuming nothing else is changed. The correlation between historical values of Pacific Biosciences' Stock Based Compensation and Capital Expenditures is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Stock Based Compensation of Pacific Biosciences of are associated (or correlated) with its Capital Expenditures. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Expenditures has no effect on the direction of Stock Based Compensation i.e., Pacific Biosciences' Stock Based Compensation and Capital Expenditures go up and down completely randomly.

Correlation Coefficient

0.59

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Capital Expenditures

Capital Expenditures are funds used by Pacific Biosciences to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Pacific Biosciences operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Most indicators from Pacific Biosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Pacific Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

The current year's Selling General Administrative is expected to grow to about 203.9 M, whereas Tax Provision is forecasted to decline to (12.9 M).

	2022	2023	2024	2025 (projected)
Gross Profit	49.0M	52.8M	60.7M	63.7M
Total Revenue	128.3M	200.5M	230.6M	242.1M

Gross Profit Total Revenue

Pacific Biosciences fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Property Plant Equipment
Common Stock Shares Outstanding		0.9	0.9	0.6	0.94	0.92	0.13	0.94	0.56	0.87	-0.96	0.91	0.6	0.91	0.11	0.03	0.83	0.89	0.86	0.94	0.98	0.87	0.96	0.86	0.51	0.95
Total Assets	0.9		1.0	0.71	0.97	0.98	0.35	0.86	0.73	0.95	-0.84	0.86	0.71	0.99	0.09	-0.16	0.97	0.99	0.99	0.91	0.91	0.99	0.89	0.98	0.35	0.96
Short Long Term Debt Total	0.9	1.0		0.73	0.97	0.96	0.29	0.85	0.71	0.97	-0.85	0.89	0.66	1.0	0.12	-0.2	0.95	0.96	0.99	0.92	0.92	0.99	0.9	0.96	0.38	0.96
Other Current Liab	0.6	0.71	0.73		0.64	0.63	0.02	0.63	0.69	0.67	-0.62	0.54	0.59	0.7	0.33	0.11	0.7	0.68	0.75	0.58	0.6	0.75	0.52	0.71	0.45	0.68
Total Current Liabilities	0.94	0.97	0.97	0.64		0.97	0.23	0.84	0.65	0.95	-0.89	0.92	0.6	0.98	0.14	-0.13	0.9	0.95	0.94	0.95	0.96	0.94	0.93	0.93	0.4	0.94
Total Stockholder Equity	0.92	0.98	0.96	0.63	0.97		0.35	0.87	0.69	0.9	-0.86	0.85	0.72	0.96	0.05	-0.08	0.95	0.99	0.93	0.92	0.93	0.94	0.9	0.97	0.3	0.95
Other Liab	0.13	0.35	0.29	0.02	0.23	0.35		0.27	0.62	0.15	-0.09	0.08	0.62	0.24	-0.2	-0.14	0.52	0.41	0.34	0.01	0.16	0.34	0.05	0.47	0.0	0.25
Property Plant And Equipment Net	0.94	0.86	0.85	0.63	0.84	0.87	0.27		0.62	0.78	-0.89	0.83	0.71	0.85	0.02	0.06	0.84	0.86	0.84	0.82	0.89	0.84	0.88	0.85	0.57	0.93
Current Deferred Revenue	0.56	0.73	0.71	0.69	0.65	0.69	0.62	0.62		0.59	-0.6	0.49	0.81	0.67	0.26	0.06	0.82	0.75	0.75	0.45	0.6	0.74	0.42	0.8	0.4	0.64
Net Debt	0.87	0.95	0.97	0.67	0.95	0.9	0.15	0.78	0.59		-0.84	0.92	0.46	0.98	0.15	-0.35	0.85	0.89	0.95	0.93	0.9	0.95	0.91	0.88	0.36	0.94
Retained Earnings	-0.96	-0.84	-0.85	-0.62	-0.89	-0.86	-0.09	-0.89	-0.6	-0.84		-0.89	-0.54	-0.86	-0.22	-0.05	-0.75	-0.82	-0.8	-0.87	-0.94	-0.81	-0.9	-0.79	-0.58	-0.9
Accounts Payable	0.91	0.86	0.89	0.54	0.92	0.85	0.08	0.83	0.49	0.92	-0.89		0.39	0.9	0.25	-0.21	0.74	0.8	0.84	0.89	0.93	0.85	0.92	0.78	0.52	0.93
Cash	0.6	0.71	0.66	0.59	0.6	0.72	0.62	0.71	0.81	0.46	-0.54	0.39		0.62	-0.01	0.32	0.84	0.78	0.7	0.47	0.56	0.69	0.47	0.81	0.3	0.62
Non Current Assets Total	0.91	0.99	1.0	0.7	0.98	0.96	0.24	0.85	0.67	0.98	-0.86	0.9	0.62		0.11	-0.21	0.93	0.96	0.98	0.94	0.93	0.99	0.92	0.95	0.36	0.97
Non Currrent Assets Other	0.11	0.09	0.12	0.33	0.14	0.05	-0.2	0.02	0.26	0.15	-0.22	0.25	-0.01	0.11		0.36	0.04	0.04	0.11	0.02	0.17	0.11	0.01	0.06	0.36	0.11
Other Assets	0.03	-0.16	-0.2	0.11	-0.13	-0.08	-0.14	0.06	0.06	-0.35	-0.05	-0.21	0.32	-0.21	0.36		-0.08	-0.07	-0.21	-0.16	-0.03	-0.2	-0.15	-0.09	0.26	-0.16
Cash And Short Term Investments	0.83	0.97	0.95	0.7	0.9	0.95	0.52	0.84	0.82	0.85	-0.75	0.74	0.84	0.93	0.04	-0.08		0.98	0.96	0.8	0.83	0.96	0.78	1.0	0.32	0.9
Short Term Investments	0.89	0.99	0.96	0.68	0.95	0.99	0.41	0.86	0.75	0.89	-0.82	0.8	0.78	0.96	0.04	-0.07	0.98		0.96	0.88	0.9	0.96	0.86	0.99	0.31	0.93
Non Current Liabilities Total	0.86	0.99	0.99	0.75	0.94	0.93	0.34	0.84	0.75	0.95	-0.8	0.84	0.7	0.98	0.11	-0.21	0.96	0.96		0.88	0.87	1.0	0.85	0.97	0.37	0.94
Other Current Assets	0.94	0.91	0.92	0.58	0.95	0.92	0.01	0.82	0.45	0.93	-0.87	0.89	0.47	0.94	0.02	-0.16	0.8	0.88	0.88		0.93	0.88	0.98	0.84	0.31	0.92
Other Stockholder Equity	0.98	0.91	0.92	0.6	0.96	0.93	0.16	0.89	0.6	0.9	-0.94	0.93	0.56	0.93	0.17	-0.03	0.83	0.9	0.87	0.93		0.88	0.95	0.87	0.47	0.94
Total Liab	0.87	0.99	0.99	0.75	0.94	0.94	0.34	0.84	0.74	0.95	-0.81	0.85	0.69	0.99	0.11	-0.2	0.96	0.96	1.0	0.88	0.88		0.86	0.97	0.38	0.95
Property Plant And Equipment Gross	0.96	0.89	0.9	0.52	0.93	0.9	0.05	0.88	0.42	0.91	-0.9	0.92	0.47	0.92	0.01	-0.15	0.78	0.86	0.85	0.98	0.95	0.86		0.82	0.38	0.93
Total Current Assets	0.86	0.98	0.96	0.71	0.93	0.97	0.47	0.85	0.8	0.88	-0.79	0.78	0.81	0.95	0.06	-0.09	1.0	0.99	0.97	0.84	0.87	0.97	0.82		0.33	0.92
Short Term Debt	0.51	0.35	0.38	0.45	0.4	0.3	0.0	0.57	0.4	0.36	-0.58	0.52	0.3	0.36	0.36	0.26	0.32	0.31	0.37	0.31	0.47	0.38	0.38	0.33		0.42
Property Plant Equipment	0.95	0.96	0.96	0.68	0.94	0.95	0.25	0.93	0.64	0.94	-0.9	0.93	0.62	0.97	0.11	-0.16	0.9	0.93	0.94	0.92	0.94	0.95	0.93	0.92	0.42

Click cells to compare fundamentals

Pacific Biosciences Account Relationship Matchups

Pacific Biosciences fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Common Stock Shares Outstanding	175.0M	204.1M	224.6M	253.6M	291.7M	306.3M
Total Assets	414.0M	2.0B	1.8B	1.7B	2.0B	2.1B
Short Long Term Debt Total	42.0M	953.7M	957.4M	933.9M	1.1B	1.1B
Other Current Liab	17.5M	40.4M	201.2M	53.5M	61.6M	64.7M
Total Current Liabilities	36.5M	83.3M	76.9M	95.0M	109.3M	114.7M
Total Stockholder Equity	335.5M	791.0M	562.9M	701.3M	806.5M	846.8M
Other Liab	2.0M	10.3M	215.0M	2.6M	3.0M	2.8M
Property Plant And Equipment Net	54.9M	79.1M	81.3M	69.0M	79.4M	83.3M
Current Deferred Revenue	10.3M	36.0M	32.3M	16.3M	18.8M	13.1M
Net Debt	(276.8M)	493.0M	632.3M	754.0M	867.1M	910.5M
Retained Earnings	(1.0B)	(1.2B)	(1.5B)	(1.8B)	(1.7B)	(1.6B)
Accounts Payable	3.6M	11.0M	12.0M	15.1M	17.3M	18.2M
Cash	318.8M	460.7M	325.1M	179.9M	206.9M	137.4M
Non Current Assets Total	59.2M	901.2M	912.1M	1.0B	1.2B	1.2B
Non Currrent Assets Other	879K	1.2M	10.5M	3.7M	4.3M	3.7M
Other Assets	33.5M	1.2M	13.5M	1.0	1.15	1.09
Cash And Short Term Investments	318.8M	1.0B	772.3M	631.4M	726.1M	762.4M
Short Term Investments	237.2M	583.7M	447.2M	451.5M	519.2M	545.2M
Liabilities And Stockholders Equity	414.0M	2.0B	1.8B	1.7B	2.0B	2.1B
Non Current Liabilities Total	42.0M	1.1B	1.1B	949.7M	1.1B	1.1B
Other Current Assets	5.7M	7.9M	10.6M	17.3M	19.9M	20.9M
Other Stockholder Equity	1.4B	2.0B	2.1B	2.5B	2.9B	3.1B
Total Liab	78.5M	1.2B	1.2B	1.0B	1.2B	1.3B
Property Plant And Equipment Gross	54.9M	79.1M	81.3M	143.8M	165.4M	173.7M
Total Current Assets	354.8M	1.1B	855.0M	742.0M	853.4M	896.0M
Accumulated Other Comprehensive Income	85K	(1.1M)	(4.8M)	219K	197.1K	207.0K
Short Term Debt	8.7M	9.3M	19.6M	10.1M	11.6M	8.2M
Property Plant Equipment	30.1M	24.9M	79.1M	81.3M	93.5M	98.2M
Net Receivables	16.8M	24.2M	18.8M	36.6M	42.1M	44.2M
Common Stock Total Equity	150K	153K	192K	221K	198.9K	189.0K
Inventory	14.2M	24.6M	50.4M	56.7M	65.2M	68.4M
Common Stock	192K	221K	227K	268K	241.2K	229.1K
Net Tangible Assets	54.9M	335.5M	(30.0M)	(257.3M)	(231.6M)	(220.0M)
Retained Earnings Total Equity	(982.1M)	(1.1B)	(1.0B)	(1.2B)	(1.1B)	(1.2B)
Non Current Liabilities Other	40.0M	178.9M	180.6M	20.3M	23.3M	22.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

When determining whether Pacific Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Pacific Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pacific Biosciences Of Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pacific Biosciences Of Stock:

How To Invest In Pacific

Details

Is Pacific Stock a good investment?

Details

What is Pacific Biosciences' Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pacific Biosciences of. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pacific Biosciences. If investors know Pacific will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pacific Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.46)

Revenue Per Share

0.64

Quarterly Revenue Growth

(0.28)

Return On Assets

(0.11)

Return On Equity

(0.65)

The market value of Pacific Biosciences is measured differently than its book value, which is the value of Pacific that is recorded on the company's balance sheet. Investors also form their own opinion of Pacific Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pacific Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pacific Biosciences' market value can be influenced by many factors that don't directly affect Pacific Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Pacific Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pacific Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pacific Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Pacific Stock Based Compensation vs Capital Expenditures Analysis

Stock Based Compensation vs Capital Expenditures

Stock Based Compensation vs Capital Expenditures Correlation Analysis

Correlation Coefficient

Stock Based Compensation

Capital Expenditures

Pacific Biosciences fundamental ratios Correlations

Pacific Biosciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Pacific Biosciences fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Short Long Term Debt Total	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Short Long Term Debt Total
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Liab	+ 1.0	Non Current Liabilities Total
Non Current Assets Total	+ 0.99	Total Assets
Short Term Investments	+ 0.99	Total Assets

Retained Earnings	- 0.96	Common Stock Shares Outstanding
Other Stockholder Equity	- 0.94	Retained Earnings
Property Plant Equipment	- 0.9	Retained Earnings
Property Plant And Equipment Gross	- 0.9	Retained Earnings
Accounts Payable	- 0.89	Retained Earnings
Retained Earnings	- 0.89	Property Plant And Equipment Net